ABSTRACT
Menetrier's disease represents a low prevalence clinical entity, characterized by complexity in its diagnosis, particularly due to the need to exclude its potential association with gastric cancer. In this context, we present the clinical case of a 54-year-old male with nonspecific gastrointestinal symptoms and hypoalbuminemia. During the upper endoscopy procedure, a noticeable thickening of gastric folds was observed, associated with multiple polypoid lesions in the stomach, predominantly in the fundus and body. Since the patient did not show improvement in symptoms and given the inability to rule out gastric cancer, total gastrectomy was chosen as the treatment. Surgical specimen and histology confirmed the presence of Menetrier's disease.
Subject(s)
Gastritis, Hypertrophic , Polyps , Humans , Male , Middle Aged , Gastritis, Hypertrophic/complications , Gastritis, Hypertrophic/diagnosis , Polyps/diagnosis , Polyps/complications , Polyps/surgery , Polyps/pathology , Stomach Diseases/diagnosis , Stomach Diseases/complications , Hyperplasia , Gastrectomy , Stomach Neoplasms/diagnosis , Stomach Neoplasms/pathology , Stomach Neoplasms/complications , Stomach Neoplasms/surgery , Adenomatous PolypsABSTRACT
BACKGROUND & AIMS: Menetrier's disease is a rare acquired disorder associated with giant gastric folds along with protein-losing enteropathy, low stomach acid, or achlorhydria, and histologic features of massive foveolar hyperplasia. Little is known about the etiology, clinical features, or epidemiology of this disorder, including risk of gastric cancer. We investigated the outcomes and characteristics of patients with Menetrier's disease, including development of gastric cancer and survival times. METHODS: We performed a case-control study of all Menetrier's disease cases (n = 76; mean age, 56 ± 45 y; 59% male; mean body mass index, 24) diagnosed at Mayo Clinic, Rochester, MN, from January 1975 through 2005. Diagnosis of Menetrier's disease was based on a combination of clinical, endoscopic, radiologic, and histologic features. Patients with dyspepsia who underwent gastric biopsy analysis were included as controls. We obtained demographic, clinical history, laboratory, imaging, histopathology, and follow-up data from medical records. Clinical characteristics of Menetrier's disease were analyzed using descriptive statistics. The Kaplan-Meier method was used to estimate overall survival in cases. RESULTS: Clinical features found in a significantly higher proportion of patients with Menetrier's disease than controls included vomiting, abdominal pain, postprandial fullness, and weight loss of 10 lb or more. Smoking was associated with Menetrier's disease (P = .002 vs controls), but not alcohol use. Infection with Helicobacter pylori was not associated with Menetrier's disease (2.6% of patients vs 4.0% of controls; P = 1.00). There was no significant difference between patients with Menetrier's disease vs controls in proportions with inflammatory bowel disease. Gastric cancer developed in 8.9% of patients with Menetrier's disease by 10 years after the Menetrier's disease diagnosis vs 3.7% of controls over the same time period (P = .09). Of patients with Menetrier's disease, 72.7% and 65.0% survived for 5 and 10 years, respectively, compared with 100% of controls (P < .0001 for both time periods). CONCLUSIONS: In a case-control study of 76 patients with Menetrier's disease, we found this rare disorder to be associated with increased mortality. Patients with Menetrier's disease therefore should be followed up with surveillance endoscopy.
Subject(s)
Gastritis, Hypertrophic , Helicobacter pylori , Stomach Neoplasms , Case-Control Studies , Female , Gastric Mucosa , Gastritis, Hypertrophic/complications , Gastritis, Hypertrophic/epidemiology , Gastroscopy , Humans , Male , Middle Aged , Stomach Neoplasms/epidemiologyABSTRACT
BACKGROUND: Ménétrier-like disease is a rare hypertrophic canine gastropathy, reported in only seven dogs. Clinical signs are vomiting, anorexia and weight loss. Macroscopically, giant cerebriform gastric mucosal folds are typically seen in the corpus and fundus of the stomach. Histopathologically, fundic mucous cell hyperplasia and loss of parietal and chief cells are typical. CASE PRESENTATION: A nine-year-old spayed female Pointer had a history of intermittent vomiting, marked weight loss and hypoalbuminaemia. A gastroduodenoscopy was performed three times within three months with macroscopic changes remaining the same. The gastric mucosa of the corpus, fundus and proximal antrum was markedly irregular, with cerebriform mucosal folds. In the first gastric biopsies, histopathology revealed a moderate granulomatous gastritis, with a severe manifestation of Helicobacter-like organisms. Treatment for Helicobacter spp. decreased the vomiting slightly. The dog was diagnosed with concurrent leishmaniosis; the conventional anti-Leishmania treatment decreased the vomiting moderately, the hypoalbuminaemia resolved and the dog gained weight back to a normal body condition. Granulomatous gastritis was not present in the gastric biopsies after these treatments. The dog increased vomiting when palliative treatment (maropitant citrate, ondansetron and esomeprazole) was discontinued, and thus, full-thickness biopsies of the stomach were taken and Ménétrier-like disease was diagnosed. The affected area was too large to be surgically removed; thus, palliative treatment was reinstated. The dog remained clinically well 39 months after the first clinical presentation. CONCLUSIONS: This is the first report of Ménétrier-like disease in a dog with a simultaneous manifestation of granulomatous gastritis, helicobacteriosis and leishmaniosis. The clinical signs decreased after treatment of helicobacteriosis and leishmaniosis, but vomiting remained probably as a sign of Ménétrier-like disease. Treatment options for dogs are surgical removal of the abnormal area or palliative treatment. In humans, promising results for a cure have been shown with cetuximab treatment, a human monoclonal antibody, but no canine antibody is commercially available yet. The dog here was doing well 39 months after first presentation, which is the longest reported survival time for Ménétrier-like disease with only palliative treatment in dogs. Full-thickness biopsies are preferred in macroscopic hypertrophic lesions of the stomach for better assessment of Ménétrier-like disease.
Subject(s)
Dog Diseases/pathology , Gastritis, Hypertrophic/veterinary , Helicobacter Infections/veterinary , Leishmaniasis/veterinary , Animals , Dog Diseases/diagnosis , Dog Diseases/microbiology , Dog Diseases/parasitology , Dogs , Female , Gastritis, Hypertrophic/diagnosis , Gastritis, Hypertrophic/drug therapy , Helicobacter , Helicobacter Infections/drug therapy , Hypoalbuminemia/veterinary , Leishmania/immunology , Leishmaniasis/drug therapy , Stomach/pathology , Stomach/surgery , Vomiting/drug therapy , Vomiting/veterinaryABSTRACT
Paediatric Menetrier disease (PMD) is a protein-losing gastropathy, presenting with generalized oedema and abdominal symptoms. PMD commonly has an acute course and may be associated with Cytomegalovirus (CMV) infection. The aim of this retrospective study is to assess the epidemiological and clinical data, diagnostic procedures, treatment and outcome of CMV-associated PMD. The medical charts of the patients with PMD and CMV infection diagnosed at our hospital have been reviewed. Then, a systematic literature's review of all the cases of PMD and a selection of those associated with CMV infection have been performed. Three previously healthy boys were admitted for vomiting and oedema. Endoscopy showed hypertrophic gastric folds and CMV infection was diagnosed. Albumin was administered in all cases, with clinical resolution within few weeks. In literature, PMD has been described in 150 children and the association between CMV and PMD was found in 89 cases. Clinical and laboratory data, radiological and histological exams, therapy and outcome were reviewed.Conclusions: Basing on the present experience and on the current knowledge, PMD has a benign course without long-term sequelae. Although PMD is rare in children, we recommend paediatricians to consider CMV-related PMD when facing children with vomiting and diffuse oedema. What is Known: ⢠Paediatricians should consider Menetrier disease (MD) when facing oedematous child complaining of abdominal symptoms with hypoalbuminemia, without proteinuria and liver dysfunction. ⢠Typical ultrasound features (hypertrophic gastric folds) suggest such condition which requires endoscopy and biopsy for definitive diagnosis. What is New: ⢠A familial susceptibility to CMV gastric infection has been recently suggested; thus when suspecting MD, the family history of gastric diseases should be investigated. ⢠Menetrier disease has been found associated with other unusual conditions either benign (such as gastric bezoar) or malign as neoplasms (acute lymphatic leukaemia and adenocarcinoma) even in children.
Subject(s)
Cytomegalovirus Infections , Gastritis, Hypertrophic , Child , Cytomegalovirus Infections/complications , Cytomegalovirus Infections/epidemiology , Gastric Mucosa , Gastritis, Hypertrophic/complications , Gastritis, Hypertrophic/diagnosis , Gastritis, Hypertrophic/epidemiology , Humans , Male , Retrospective StudiesABSTRACT
BACKGROUND: Ménétrier's disease (MD) is a protein-losing gastropathy characterized by gastric hypertrophy, foveolar hyperplasia and hypoalbuminemia. MD is uncommon in childhood with nonspecific clinical symptoms, and the exact cause of pediatric MD is still unclear. CASE PRESENTATION: Here, we reported a 4 year and 10-month boy presenting with MD from China. The patient was suffered with vomiting, abdominal pain, hypoproteinemia and edema. Laboratory tests showed that the boy was infected with Clostridium difficile (CD). Gastrointestinal endoscopy revealed giant gastric folds, and histological gastric biopsies showed foveolar hyperplasia with glandular atrophy, infiltration of eosinophils in the lamina propria of the patient. Finally, the boy was recovered after supportive therapy with intravenous albumin and CD eradication. CONCLUSION: For the nonspecific clinical symptoms of MD, gastrointestinal endoscopic evaluations with gastric tissue biopsies are required to establish the diagnosis of MD in children with unexplained hypoalbuminemia.
Subject(s)
Gastritis, Hypertrophic , Child , China , Gastric Mucosa , Gastritis, Hypertrophic/complications , Gastritis, Hypertrophic/diagnosis , Humans , Infant , MaleABSTRACT
We performed whole exome sequencing in individuals from a family with autosomal dominant gastropathy resembling Ménétrier disease, a premalignant gastric disorder with epithelial hyperplasia and enhanced EGFR signalling. Ménétrier disease is believed to be an acquired disorder, but its aetiology is unknown. In affected members, we found a missense p.V742G variant in MIB2, a gene regulating NOTCH signalling that has not been previously linked to human diseases. The variant segregated with the disease in the pedigree, affected a highly conserved amino acid residue, and was predicted to be deleterious although it was found with a low frequency in control individuals. The purified protein carrying the p.V742G variant showed reduced ubiquitination activity in vitro and white blood cells from affected individuals exhibited significant reductions of HES1 and NOTCH3 expression reflecting alteration of NOTCH signalling. Because mutations of MIB1, the homolog of MIB2, have been found in patients with left ventricle non-compaction (LVNC), we investigated members of our family with Ménétrier-like disease for this cardiac abnormality. Asymptomatic left ventricular hypertrabeculation, the mildest end of the LVNC spectrum, was detected in two members carrying the MIB2 variant. Finally, we identified an additional MIB2 variant (p.V984L) affecting protein stability in an unrelated isolated case with LVNC. Expression of both MIB2 variants affected NOTCH signalling, proliferation and apoptosis in primary rat cardiomyocytes.In conclusion, we report the first example of left ventricular hypertrabeculation/LVNC with germline MIB2 variants resulting in altered NOTCH signalling that might be associated with a gastropathy clinically overlapping with Ménétrier disease.
Subject(s)
Cardiomyopathies/pathology , Gastritis, Hypertrophic/pathology , Mutation, Missense/genetics , Receptors, Notch/metabolism , Stomach Diseases/pathology , Ubiquitin-Protein Ligases/genetics , Ventricular Dysfunction, Left/pathology , Animals , Animals, Newborn , Cardiomyopathies/etiology , Cardiomyopathies/metabolism , Case-Control Studies , Cells, Cultured , Exome/genetics , Female , Gastritis, Hypertrophic/etiology , Gastritis, Hypertrophic/metabolism , Gene Expression Regulation , Humans , Male , Myocytes, Cardiac/cytology , Myocytes, Cardiac/metabolism , Pedigree , Phenotype , Rats , Receptors, Notch/genetics , Signal Transduction , Stomach Diseases/etiology , Stomach Diseases/metabolism , Ubiquitin-Protein Ligases/metabolism , Ubiquitination , Ventricular Dysfunction, Left/etiology , Ventricular Dysfunction, Left/metabolismSubject(s)
Antibodies, Monoclonal, Humanized/pharmacology , Antibodies, Neutralizing/pharmacology , Colonic Neoplasms/drug therapy , ErbB Receptors/immunology , Gastritis, Hypertrophic/drug therapy , Animals , Antibodies, Monoclonal, Humanized/therapeutic use , Antibodies, Neutralizing/therapeutic use , Azoxymethane/toxicity , Carcinogens/toxicity , Cells, Cultured , Colonic Neoplasms/chemically induced , Colonic Neoplasms/immunology , Colonic Neoplasms/pathology , Dextran Sulfate/toxicity , Disease Models, Animal , ErbB Receptors/genetics , Gastritis, Hypertrophic/genetics , Gastritis, Hypertrophic/immunology , Gastritis, Hypertrophic/pathology , Genes, Reporter/genetics , Genes, Reporter/immunology , Hepatocytes , Humans , Mice , Mice, Transgenic , Primary Cell CultureABSTRACT
Ménétrier disease is a rare condition of an unknown origin, with a wide spectrum of clinical signs and symptoms at presentation. Diagnosis is made through the combination of clinical, analytical, endoscopic and histological data. Surgery is the classical treatment. However, new medical approaches have emerged.
Subject(s)
Anemia, Iron-Deficiency/etiology , Gastritis, Hypertrophic/complications , Anemia, Iron-Deficiency/diagnosis , Gastrectomy , Gastritis, Hypertrophic/diagnosis , Gastritis, Hypertrophic/surgery , Humans , Male , Middle AgedABSTRACT
A 54-year-old man presented to our department with abdominal discomfort and anorexia and was diagnosed as having Ménétrier's disease (MD) with hilar cholangiocarcinoma. Based on his clinical examination, there was no evidence of Helicobacter pylori or cytomegalovirus (CMV) infection. Although we administered proton pump inhibitor and high-calorie enteral nutrition, hypoproteinemia did not improve, and the refractory protein-losing enteropathy persisted. However, interestingly, MD improved immediately after resection of the hilar cholangiocarcinoma. Generally, the etiology of MD is unknown, but H. pylori and CMV infections have been implicated. To our knowledge, there has been no previous report indicating that a malignant tumor could be involved in the etiology of MD. Thus, we report an extremely rare case of MD which is seemingly caused by malignancy.
Subject(s)
Bile Duct Neoplasms/complications , Gastritis, Hypertrophic/etiology , Klatskin Tumor/complications , Bile Duct Neoplasms/diagnostic imaging , Bile Duct Neoplasms/therapy , Biopsy , Gastritis, Hypertrophic/diagnostic imaging , Gastritis, Hypertrophic/pathology , Humans , Klatskin Tumor/diagnostic imaging , Klatskin Tumor/therapy , Male , Middle Aged , Treatment OutcomeABSTRACT
Epidemiological studies have demonstrated a close association between infection with Helicobacter pylori (H.pylori) and the development of gastric carcinoma. Chronic H.pylori infection increases the frequency of mutation in gastric epithelial cells. However, the mechanism by which infection of H.pylori leads to mutation in gastric epithelial cells is unclear. We suspected that components in H.pylori may be related to the mutagenic response associated with DNA alkylation, and could be detected with the Ames test using a more sensitive strain for alkylating agents. Our investigation revealed that an extract of H.pylori was mutagenic in the Ames test with Salmonella typhimurium YG7108, which is deficient in the DNA repair of O(6)-methylguanine. The extract of H.pylori may contain methylating or alkylating agents, which might induce O (6)-alkylguanine in DNA. Mutagenicity of the alkylating agents N-methyl-N-nitrosourea (MNU) and N-methyl-N'-nitro-N-nitrosoguanidine in the Ames test with S.typhimurium TA1535 was enhanced significantly in the presence of the extract of H.pylori. The tested extracts of H.pylori resulted in a significant induction of micronuclei in human-derived lymphoblastoid cells. Heat instability and dialysis resistance of the extracts of H.pylori suggest that the mutagenic component in the extracts of H.pylori is a heat-unstable large molecule or a heat-labile small molecule strongly attached or adsorbed to a large molecule. Proteins in the extracts of H.pylori were subsequently fractionated using ammonium sulphate precipitation. However, all fractions expressed enhancing effects toward MNU mutagenicity. These results suggest the mutagenic component is a small molecule that is absorbed into proteins in the extract of H.pylori, which resist dialysis. Continuous and chronic exposure of gastric epithelial cells to the alkylative mutagenic component from H.pylori chronically infected in the stomach might be a causal factor in the gastric carcinogenesis associated with H.pylori.
Subject(s)
Cell Extracts/pharmacology , DNA Damage/drug effects , Helicobacter Infections/microbiology , Helicobacter pylori/pathogenicity , Lymphocytes/drug effects , Mutagens/pharmacology , Anemia, Iron-Deficiency/microbiology , Anemia, Iron-Deficiency/pathology , Cells, Cultured , DNA Repair/drug effects , Gastritis, Hypertrophic/microbiology , Gastritis, Hypertrophic/pathology , Helicobacter Infections/pathology , Helicobacter pylori/isolation & purification , Humans , Lymphocytes/metabolism , Micronucleus Tests/methods , Mutagenicity Tests/methods , Mutation/genetics , Salmonella typhimurium/drug effects , Salmonella typhimurium/genetics , Stomach Ulcer/microbiology , Stomach Ulcer/pathologyABSTRACT
Menetrier disease (MD) is a very rare stomach pathology of unknown etiology characterized by manifest hypertrophy of gastric mucosa. The main causes of MD are believed to be Helicobacter pylori and cytomegalovirus infections. The most frequent symptom is epigastric pain. Also common are peripheral oedema due to hypoalbuminemia and increased permeability of gastric mucosa. The main diagnostic signs of MD include diffusive enhancement of mucosal folds, foveolar hyperplasia and glandular atrophy with a decrease in the number of main and parietal cells, hypoalbuminemia and peripheral oedema. MD being a very rare condition, the optimal methodfor its treatment is unknown.
Subject(s)
Gastritis, Hypertrophic , Gastritis, Hypertrophic/diagnosis , Gastritis, Hypertrophic/etiology , Gastritis, Hypertrophic/physiopathology , Gastritis, Hypertrophic/therapy , HumansABSTRACT
Analysis of cellular signaling networks typically involves targeted measurements of phosphorylated protein intermediates. However, phosphoproteomic analyses usually require affinity enrichment of phosphopeptides and can be complicated by artifactual changes in phosphorylation caused by uncontrolled preanalytical variables, particularly in the analysis of tissue specimens. We asked whether changes in protein expression, which are more stable and easily analyzed, could reflect network stimulation and inhibition. We employed this approach to analyze stimulation and inhibition of the epidermal growth factor receptor (EGFR) by EGF and selective EGFR inhibitors. Shotgun analysis of proteomes from proliferating A431 cells, EGF-stimulated cells, and cells co-treated with the EGFR inhibitors cetuximab or gefitinib identified groups of differentially expressed proteins. Comparisons of these protein groups identified 13 proteins whose EGF-induced expression changes were reversed by both EGFR inhibitors. Targeted multiple reaction monitoring analysis verified differential expression of 12 of these proteins, which comprise a candidate EGFR inhibition signature. We then tested these 12 proteins by multiple reaction monitoring analysis in three other models: 1) a comparison of DiFi (EGFR inhibitor-sensitive) and HCT116 (EGFR-insensitive) cell lines, 2) in formalin-fixed, paraffin-embedded mouse xenograft DiFi and HCT116 tumors, and 3) in tissue biopsies from a patient with the gastric hyperproliferative disorder Ménétrier's disease who was treated with cetuximab. Of the proteins in the candidate signature, a core group, including c-Jun, Jagged-1, and Claudin 4, were decreased by EGFR inhibitors in all three models. Although the goal of these studies was not to validate a clinically useful EGFR inhibition signature, the results confirm the hypothesis that clinically used EGFR inhibitors generate characteristic protein expression changes. This work further outlines a prototypical approach to derive and test protein expression signatures for drug action on signaling networks.
Subject(s)
Antineoplastic Agents/pharmacology , Colorectal Neoplasms/metabolism , ErbB Receptors/antagonists & inhibitors , ErbB Receptors/metabolism , Gastritis, Hypertrophic/metabolism , Neoplasms, Glandular and Epithelial/metabolism , Neoplasms/metabolism , Proteomics , Animals , Antibodies, Monoclonal/pharmacology , Antibodies, Monoclonal, Humanized , Blotting, Western , Cell Line, Tumor , Cell Proliferation/drug effects , Cetuximab , Chromatography, Liquid , Colorectal Neoplasms/drug therapy , Epidermal Growth Factor/pharmacology , Gastritis, Hypertrophic/drug therapy , Gefitinib , Humans , Mice , Neoplasms/drug therapy , Neoplasms, Glandular and Epithelial/drug therapy , Phosphorylation/drug effects , Prospective Studies , Quinazolines/pharmacology , Signal Transduction/drug effects , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Transplantation, HeterologousABSTRACT
A 4 yr old castrated male Jack Russell terrier was presented with a 2 mo history of vomiting, anorexia, and weight loss. Abdominal radiographs and ultrasound supported the diagnosis of gastric outflow obstruction. Celiotomy and gastrotomy revealed a large, narrowly based mass originating from the mucosa of the dorsal gastric body, occupying the lumen of the stomach and protruding through the pylorus into the duodenum. A partial gastrectomy was performed to excise the mass along with a 1 cm margin of grossly normal tissue. Giant hypertrophic gastritis was diagnosed via histopathology of the excised tissue. Giant hypertrophic gastritis is a rarely diagnosed disease of canines, characterized by giant gastric folds, hypoalbuminemia, and mucosal hypertrophy. Long-term treatment success has not been previously reported. In the case described herein, surgical excision of the affected gastric tissue provided complete resolution of clinical signs. Twelve mo following surgery, no recurrence of either vomiting or weight loss had been noted and the dog was clinically normal.
Subject(s)
Dog Diseases/diagnosis , Dog Diseases/surgery , Gastritis, Hypertrophic/veterinary , Animals , Diagnosis, Differential , Dog Diseases/pathology , Dogs , Gastrectomy/veterinary , Gastritis, Hypertrophic/surgery , MaleSubject(s)
Gastritis, Hypertrophic/pathology , Immunoglobulin G4-Related Disease/pathology , Aged , Biopsy , Female , Gastric Mucosa/pathology , Gastritis, Hypertrophic/diagnostic imaging , Gastroscopy/methods , Humans , Immunoglobulin G4-Related Disease/diagnostic imaging , Immunohistochemistry , Pancreatitis/pathology , Tomography, X-Ray Computed/methodsABSTRACT
Alterations of the stomach mucosa in response to different adverse effects result in various morphological and clinical symptoms. Gastric mucosa alterations can be classified on the bases of diverse viewpoints. It makes this overview difficult, that identical toxic effects may cause different mucosal changes and different toxic agents may produce similar mucosal appearance. The more accurate understanding of the pathological processes which develop in the stomach mucosa needs reconsideration. The authors make an attempt to define gastritis and gastropathy in order to classify and present their features. Gastritis is a histological definition indicating mucosal inflammation. Acute gastritis is caused by infections. The two most important forms of chronic gastritis are metaplastic atrophic gastritis with an autoimmune origin and Helicobacter pylori inflammation. Gastropathy is the name of different structural alterations of the mucosa. Its most important feature is the paucity of inflammatory signs. Gastropathies can be divided into 4 categories based on the nature of the underlying pathological effect, on its morphological appearance and the way of the development. Differential diagnosis is an important pathological and clinical task because different treatment methods and prognosis.
Subject(s)
Gastric Mucosa/pathology , Gastritis , Helicobacter Infections/complications , Acute Disease , Chronic Disease , Collagen/metabolism , Eosinophils , Gastric Mucosa/drug effects , Gastric Mucosa/immunology , Gastritis/chemically induced , Gastritis/classification , Gastritis/diagnosis , Gastritis/immunology , Gastritis/metabolism , Gastritis/microbiology , Gastritis/pathology , Gastritis, Atrophic/diagnosis , Gastritis, Hypertrophic/diagnosis , Gastroscopy , Helicobacter pylori/isolation & purification , Humans , LymphocytesABSTRACT
INTRODUCTION: Ménétrier disease is a rare disorder characterized by gastric foveolar hyperplasia associated with secondary protein loss. In children, this condition is presented as an edematous syndrome without renal or hepatic impairment and differs from the adult form by the constant presence of edema and spontaneous remission. It has been related to infections in most published cases, especially to Cytomegalovirus (CMV) and Helicobacter pylori (H. pylori). OBJECTIVE: To present a pediatric case of Ménétrier disease and endoscopic imaging obtained during the evolution of the patient. CASE REPORT: A five year old preschooler who presented a generalized edema, abdominal pain and malaise. After ruling out renal and hepatic pathologies, an upper endoscopy revealed a severe compromise of the gastric mucosa. Urease test for H. pylori and IgG test for CMV resulted positive. Albumin and H2 receptor antagonists were administered. The evolution was favorable and the patient was discharged after 14 days; 8 month follow-up endoscopy showed no abnormalities. CONCLUSION: The medical profile and endoscopy are enough evidence to suggest the diagnosis of hypertrophic protein-losing gastropathy. Further studies need to be developed that include a considerable number of patients to assess their association with CMV or H. pylori infections, as these viruses are very common in our population.